The prognostic biomarkers for multiple myeloma (MM) was urgently needed, and this study was the first to confirm the value of Intravoxel Incoherent Motion-Diffusion Weighted Imaging (IVIM-DWI) for predicting progression-free survival in patients with MM.Purpose: To evaluate the prognostic ability of Intravoxel Incoherent Motion-Diffusion Weighted Imaging (IVIM-DWI) derived parameters in newly diagnosed multiple myeloma (MM).
This abstract and the presentation materials are available to members only; a login is required.